In Brief: Laboratory practices
Executive Summary
Laboratory practices: Meeting to be held Nov. 20 to discuss issues of mutual concern to FDA and industry regarding pharmaceutical laboratory practices and procedures. Future meetings on the subject will address acceptable "best practices," research/quality assurance, acceptable uses of technology, changes in technology and pharmaceutical science-data integrity. Topics and comments may be submitted by Nov. 8. The meeting will be held in conference room E of FDA's Parklawn building starting at 8:30 a.m...